KRAS G12D INHIBITORS

يتعلق الاختراع الحالي بمركبات تثبط compounds that inhibit KRas G12D. على وجه التحديد، يتعلق الاختراع الحالي بمركبات تثبط compounds that inhibit نشاط activity KRas G12D، تركيبات صيدلية تشتمل على المركبات compounds وطرق لاستخدامها. The present invention relates to compounds that inhibit KRas G12D. In...

Full description

Saved in:
Bibliographic Details
Main Authors Macedonio J. MEJIA, James Gail CHRISTENSEN, Michael Christopher HILTON, Martha E. RODRIGUEZ, James Francis BLAKE, Xiaolun WANG, Pavel SAVECHENKOV, Shelley ALLEN, Mark Joseph CHICARELLI, Brad NEWHOUSE, John GAUDINO, Qian ZHAO, Spencer PAJK, John David LAWSON, Donghua DAI, Tony P. TANG, John Peter FISCHER, Dean Russell KAHN, Aaron Craig BURNS, Guy P. A. VIGERS, Jacob Matthew O'LEARY, Christopher Ronald SMITH, Matthew Arnold MARX, Joshua Ryan DAHLKE, John Michael KETCHAM, Phong NGUYEN, Jay Bradford FELL
Format Patent
LanguageArabic
English
Published 28.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:يتعلق الاختراع الحالي بمركبات تثبط compounds that inhibit KRas G12D. على وجه التحديد، يتعلق الاختراع الحالي بمركبات تثبط compounds that inhibit نشاط activity KRas G12D، تركيبات صيدلية تشتمل على المركبات compounds وطرق لاستخدامها. The present invention relates to compounds that inhibit KRas G12D. In particular, the present invention relates to compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor.
Bibliography:Application Number: SA20225431801